[High-risk obstetric surgery: Can we do without Cell-saver in France in 2024?]

Abstract

Certain obstetric situations, such as abnormalities in placental invasion, present a major hemorrhagic risk often requiring massive transfusion. To reduce complications associated with massive transfusions and minimize the use of the labile blood product stock, perioperative blood salvage techniques, such as the Cell-saver, have been developed, including in obstetrics. The aim of this article is to provide an update on the use of the Cell-saver in obstetrics, particularly during high hemorrhagic risk obstetric surgeries (such as surgeries for placenta accreta). Firstly, we will review the indications for using the Cell-saver in obstetrics and the technical modalities described in the literature and at our expert center. Secondly, in light of the literature data, we will list the benefits associated with the use of the Cell-saver in obstetrics as well as its risks, complications, and contraindications.